RolandoMarioVianiMDM.T.P.
Pediatric Infectious Disease • San Diego, CAHIV/AIDS Pediatrics, Pediatric Travel and Tropical Medicine
Professor, Pediatrics, UCSD School of Medicine
Dr. Viani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3020 Childrens Way
San Diego, CA 92123Phone+1 858-966-7785- Is this information wrong?
Summary
- Currently I am a Professor of Clinical Pediatrics in the Division of Infectious Diseases at the University of California San Diego, School of Medicine and Rady Children’s Hospital San Diego. I am director of the UCSD-Baja California Perinatal HIV Program in charge of conducting clinical research and clinical mentoring in Tijuana, Baja California. I am Board certified in Pediatric Infectious Diseases and have over 20 years of experience as pediatric infectious diseases, tropical medicine and HIV medicine consultant. I have conducted clinical and research mentoring in Mexico, South Africa, Mozambique and Peru. I am member of the National institute of Health sponsored International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, HIV Treatment Scientific Committee. In that capacity, I have worked in close collaboration with the pharmaceutical industry, leading the design and implementation of Phase I/II pharmacokinetic and safety studies of new antiretrovirals for adolescents, children and infants to be conducted in the US and internationally. These studies are done in close collaboration with other members of IMPAACT and diverse pharmaceutical companies, such as Schering Plough and Merck for IMPAACT P1071-vicriviroc in treatment experienced children and adolescents, Tibotec Pharmaceuticals-Janssen for IMPAACT 1090, etravirine in children and recently with GSK-ViiV for IMPAACT P1093, a phase I/II study on the new integrase inhibitor, dolutegravir. The dolutegravir study is a very successful registrational trial that enabled ViiV the necessary data for simultaneous submission to the FDA for approval in adults and children 12 years and older, culminating a successful collaboration between academia and industry. I have over 30 peer reviewed publications in the area of HIV Medicine, Tuberculosis and Malaria and have presented my work at numerous conferences worldwide.
Education & Training
University of California (San Diego) Medical CenterFellowship, Pediatric Infectious Diseases, 1995 - 1998
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1991 - 1995
Liverpool School of Tropical MedicineMasters, Tropical Paediatrics, 1990
Cayetano Heredia UniversityClass of 1984- Universidad Peruana Cayetano HerediaPre-Medical, 1974 - 1976
Certifications & Licensure
CA State Medical License 1995 - 2025- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Connect to Protect Partnerships for Youth Prevention Interventions: Phase II Start of enrollment: 2003 Sep 01
- Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth Start of enrollment: 2004 Jan 01
- Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsRezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial.George Richard Thompson, Alex Soriano, Athanasios Skoutelis, Jose A. Vazquez, Patrick M. Honore, Juan Pablo Horcajada, Herbert D. Spapen, Matteo Bassetti, Luis Ostrosk...> ;Clinical Infectious Diseases. 2020 Sep 21
- 25 citationsLong-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.Rolando M. Viani, Theodore Ruel, Carmelita Alvero, Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen Townley, Paul Palumbo, Ann M. Buchanan, Cindy Vavro, Rajendra Sin...> ;Journal of the Pediatric Infectious Diseases Society. 2020 Apr 30
- 13 citationsDrug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus AntiretroviralsMatthew P. Kosloski, Rajneet K. Oberoi, Stanley Wang, Rolando M Viani, Armen Asatryan, Beibei Hu, Bifeng Ding, Xin Qi, Elaine J. Kim, Federico J. Mensa, Jens Kort, Wei...> ;The Journal of Infectious Diseases. 2020 Jan 2
- Join now to see all
Journal Articles
- Role of Etravirine in the Management of Treatment Experienced Patients with Human Immunodeficiency Virus Type 1Viani RM, HIV/AIDS-Research and Palliative Care, 1/1/2010
- Poor Outcome Is Associated with Delayed Tuberculosis Diagnosis in HIV Infected Children in Baja California MexicoViani RM, Lopez G, Chacon-Cruz E, Hubbard P, Spector SA, Int J Tuberc Lung Dis, 1/1/2008
- Prevalence of Primary HIV-1 Drug Resistance Among Recently Infected Adolescents; A Multicenter Adolescent Trials Network for HIV/AIDS Intervention StudyViani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie Y, Weidler J, Bates M, Liu N, and Wilson C, J Infect Dis, 1/1/2006
Professional Memberships
- Fellow
Other Languages
- Spanish, Italian
Hospital Affiliations
Rady Children's Hospital - San DiegoSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
